Pfizer Inc. will spin off four experimental drugs that it had decided to shelve into a new company, called SpringWorks Therapeutics, to give them a better chance to get developed with the backing of outside investors including Bain Capital.
Shares of Pfizer Inc. (NYSE:PFE) are finally starting to catch a bid which is encouraging. Shares have been pretty much range bound for the past 24 months or so but finally broke through $36 a share last week which looks significant.
(Reuters) - Drugmaker Pfizer Inc (PFE.N) on Wednesday filed a lawsuit against Johnson & Johnson (JNJ.N), saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of ...
(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.
The US Food and Drug Administration has sent a damning warning letter to drug giant Pfizer Inc (NYSE:PFE) after it received “hundreds of complaints” that the anti-allergy EpiPen device misfired “during life-threatening emergencies”.